{"transactions":[{"id":2623361,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Option (right to buy)","published_at":"2021-07-29T00:06:41.000Z","date":"2021-07-26","kind":"exercise","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, representing the right to purchase a total of 75,000 shares of Exelixis, Inc. common stock, became fully exercisable on February 11, 2020."}],"balance_after":0,"derivative":{"exercise_price":4.2,"exercise_date":"2017-02-11","expiration_date":"2023-02-10","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000939767-21-000074","document":"wf-form4_162751718585473.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000074/wf-form4_162751718585473.xml","form_type":"4"}},{"id":2623360,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2021-07-29T00:06:41.000Z","date":"2021-07-26","kind":"exercise","acquired":true,"shares":40000,"price":4.2,"value":168000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 243,968 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":689078,"source":{"system":"sec-edgar","filing":"0000939767-21-000074","document":"wf-form4_162751718585473.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000074/wf-form4_162751718585473.xml","form_type":"4"}},{"id":2626532,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Option (right to buy)","published_at":"2021-07-23T23:47:51.000Z","date":"2021-07-21","kind":"exercise","acquired":false,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, representing the right to purchase a total of 75,000 shares of Exelixis, Inc. common stock, became fully exercisable on February 11, 2020."}],"balance_after":40000,"derivative":{"exercise_price":4.2,"exercise_date":"2017-02-11","expiration_date":"2023-02-10","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000939767-21-000073","document":"wf-form4_162708405215652.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000073/wf-form4_162708405215652.xml","form_type":"4"}},{"id":2626531,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2021-07-23T23:47:51.000Z","date":"2021-07-21","kind":"exercise","acquired":true,"shares":35000,"price":4.2,"value":147000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 243,968 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":649078,"source":{"system":"sec-edgar","filing":"0000939767-21-000073","document":"wf-form4_162708405215652.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000073/wf-form4_162708405215652.xml","form_type":"4"}},{"id":2644478,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-02T11:59:36.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the options are scheduled to vest on the first anniversary of the grant date."}],"balance_after":15000,"derivative":{"exercise_price":2.33,"exercise_date":"2022-07-01","expiration_date":"2031-07-01","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001457612-21-000084","document":"wf-form4_162524156338401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761221000084/wf-form4_162524156338401.xml","form_type":"4"}},{"id":2713047,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Option (right to buy)","published_at":"2021-05-15T00:35:07.000Z","date":"2021-05-13","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, representing the right to purchase a total of 250,000 shares of Exelixis, Inc. common stock, became fully exercisable on April 28, 2016."}],"balance_after":150000,"derivative":{"exercise_price":1.9,"exercise_date":"2015-07-20","expiration_date":"2022-02-04","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000939767-21-000050","document":"wf-form4_162103888892358.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000050/wf-form4_162103888892358.xml","form_type":"4"}},{"id":2713046,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2021-05-15T00:35:07.000Z","date":"2021-05-13","kind":"sale","acquired":false,"shares":100000,"price":25.38,"value":2538000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 25, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $25.15 to $25.65. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4."}],"balance_after":614078,"source":{"system":"sec-edgar","filing":"0000939767-21-000050","document":"wf-form4_162103888892358.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000050/wf-form4_162103888892358.xml","form_type":"4"}},{"id":2713045,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2021-05-15T00:35:07.000Z","date":"2021-05-13","kind":"exercise","acquired":true,"shares":100000,"price":1.9,"value":190000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 243,968 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 596 shares of common stock acquired on April 30, 2021, pursuant to the Exelixis, Inc. 2000 Employee Stock Purchase Plan."}],"balance_after":714078,"source":{"system":"sec-edgar","filing":"0000939767-21-000050","document":"wf-form4_162103888892358.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000050/wf-form4_162103888892358.xml","form_type":"4"}},{"id":2737665,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Option (right to buy)","published_at":"2021-04-29T00:10:23.000Z","date":"2021-04-26","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, representing the right to purchase a total of 500,000 shares of Exelixis, Inc. common stock, became fully exercisable on April 28, 2016."}],"balance_after":0,"derivative":{"exercise_price":1.7,"exercise_date":"2015-07-20","expiration_date":"2021-09-18","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000939767-21-000043","document":"wf-form4_161965500597259.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000043/wf-form4_161965500597259.xml","form_type":"4"}},{"id":2737664,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2021-04-29T00:10:23.000Z","date":"2021-04-26","kind":"sale","acquired":false,"shares":50000,"price":25,"value":1250000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 25, 2021."}],"balance_after":613482,"source":{"system":"sec-edgar","filing":"0000939767-21-000043","document":"wf-form4_161965500597259.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000043/wf-form4_161965500597259.xml","form_type":"4"}},{"id":2737663,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2021-04-29T00:10:23.000Z","date":"2021-04-26","kind":"exercise","acquired":true,"shares":50000,"price":1.7,"value":85000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 243,968 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":663482,"source":{"system":"sec-edgar","filing":"0000939767-21-000043","document":"wf-form4_161965500597259.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000043/wf-form4_161965500597259.xml","form_type":"4"}},{"id":2762474,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Option (right to buy)","published_at":"2021-04-02T23:41:37.000Z","date":"2021-04-01","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, representing the right to purchase a total of 500,000 shares of Exelixis, Inc. common stock, became fully exercisable on April 28, 2016."}],"balance_after":50000,"derivative":{"exercise_price":1.7,"exercise_date":"2015-07-20","expiration_date":"2021-09-18","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000939767-21-000039","document":"wf-form4_161740683370551.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000039/wf-form4_161740683370551.xml","form_type":"4"}},{"id":2762473,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2021-04-02T23:41:37.000Z","date":"2021-04-01","kind":"sale","acquired":false,"shares":50000,"price":23,"value":1150000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 25, 2021."}],"balance_after":613482,"source":{"system":"sec-edgar","filing":"0000939767-21-000039","document":"wf-form4_161740683370551.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000039/wf-form4_161740683370551.xml","form_type":"4"}},{"id":2762472,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2021-04-02T23:41:37.000Z","date":"2021-04-01","kind":"exercise","acquired":true,"shares":50000,"price":1.7,"value":85000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 243,968 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":663482,"source":{"system":"sec-edgar","filing":"0000939767-21-000039","document":"wf-form4_161740683370551.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000039/wf-form4_161740683370551.xml","form_type":"4"}},{"id":2807254,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2021-03-06T01:03:03.000Z","date":"2021-03-04","kind":"grant","acquired":true,"shares":72885,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Exelixis, Inc. common stock issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 1/4th of the original number of shares subject to the restricted stock unit award on May 15, 2022 and thereafter as to 1/4th of the original number of shares subject to the restricted stock unit award on each May 15th until fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 243,968 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":613482,"source":{"system":"sec-edgar","filing":"0000939767-21-000035","document":"wf-form4_161499254775903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000035/wf-form4_161499254775903.xml","form_type":"4"}},{"id":2847175,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Option (right to buy)","published_at":"2021-02-20T00:57:13.000Z","date":"2021-02-18","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, representing the right to purchase a total of 500,000 shares of Exelixis, Inc. common stock, became fully exercisable on April 28, 2016."}],"balance_after":100000,"derivative":{"exercise_price":1.7,"exercise_date":"2015-07-20","expiration_date":"2021-09-18","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000939767-21-000021","document":"wf-form4_161378260922150.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000021/wf-form4_161378260922150.xml","form_type":"4"}},{"id":2847174,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Option (right to buy)","published_at":"2021-02-20T00:57:13.000Z","date":"2021-02-17","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, representing the right to purchase a total of 500,000 shares of Exelixis, Inc. common stock, became fully exercisable on April 28, 2016."}],"balance_after":150000,"derivative":{"exercise_price":1.7,"exercise_date":"2015-07-20","expiration_date":"2021-09-18","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000939767-21-000021","document":"wf-form4_161378260922150.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000021/wf-form4_161378260922150.xml","form_type":"4"}},{"id":2847173,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2021-02-20T00:57:13.000Z","date":"2021-02-18","kind":"sale","acquired":false,"shares":50000,"price":22.35,"value":1117500.0,"ownership":{"direct":true},"balance_after":540597,"source":{"system":"sec-edgar","filing":"0000939767-21-000021","document":"wf-form4_161378260922150.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000021/wf-form4_161378260922150.xml","form_type":"4"}},{"id":2847172,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2021-02-20T00:57:13.000Z","date":"2021-02-18","kind":"exercise","acquired":true,"shares":50000,"price":1.7,"value":85000.0,"ownership":{"direct":true},"balance_after":590597,"source":{"system":"sec-edgar","filing":"0000939767-21-000021","document":"wf-form4_161378260922150.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000021/wf-form4_161378260922150.xml","form_type":"4"}},{"id":2847171,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2021-02-20T00:57:13.000Z","date":"2021-02-17","kind":"sale","acquired":false,"shares":50000,"price":22.5,"value":1125000.0,"ownership":{"direct":true},"balance_after":540597,"source":{"system":"sec-edgar","filing":"0000939767-21-000021","document":"wf-form4_161378260922150.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000021/wf-form4_161378260922150.xml","form_type":"4"}},{"id":2847170,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2021-02-20T00:57:13.000Z","date":"2021-02-17","kind":"exercise","acquired":true,"shares":50000,"price":1.7,"value":85000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 171,083 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":590597,"source":{"system":"sec-edgar","filing":"0000939767-21-000021","document":"wf-form4_161378260922150.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000021/wf-form4_161378260922150.xml","form_type":"4"}},{"id":2856027,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2021-02-18T01:10:26.000Z","date":"2021-02-15","kind":"tax_withholding","acquired":false,"shares":2858,"price":21.91,"value":62618.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on September 10, 2018, for which the Compensation Committee certified that Exelixis, Inc. had achieved the performance goal on December 4, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 171,083 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":540597,"source":{"system":"sec-edgar","filing":"0000939767-21-000017","document":"wf-form4_161361060987212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000017/wf-form4_161361060987212.xml","form_type":"4"}},{"id":2877819,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2021-02-06T02:16:03.000Z","date":"2021-02-03","kind":"tax_withholding","acquired":false,"shares":14982,"price":22.56,"value":337993.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F8","text":"Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of certain restricted stock units earned on February 3, 2021."}],"balance_after":543455,"source":{"system":"sec-edgar","filing":"0000939767-21-000010","document":"wf-form4_161257775017168.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000010/wf-form4_161257775017168.xml","form_type":"4"}},{"id":2877818,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2021-02-06T02:16:03.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":71293,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Exelixis, Inc. common stock issued to the Reporting Person upon vesting of restricted stock units.  Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F5","text":"On September 20, 2019, the Reporting Person was granted a PSU award the under 2017 Equity Incentive Plan covering 142,586 shares of common stock (such award, the \"2019 Award,\" and such shares, the \"Target Shares\"). The 2019 Award generally vests as follows: (i) 50% of the Target Shares vest upon the Committee's certification of achievement certain performance criteria as certified by Committee; and (ii) 50% of the Target Shares vest on the first quarterly PSU vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the one-year anniversary of the Committee's certification. In addition, the 2019 Award provides for vesting of up to a maximum of 200% of the Target Shares depending on the timing and level of achievement of the performance criteria provided for under the 2019 Award."},{"field":"shares","element":"transactionShares","label":"F6","text":"On February 3, 2021, the Committee determined the maximum performance criteria had been achieved, resulting in the Reporting Person's eligibility to vest up to 200% of the Target Shares subject to the 2019 Award. Accordingly, the Committee's certification resulted in the immediate vesting of 25% of the Target Shares, and the remaining 25% of the Target Shares will vest on February 15, 2022, subject to the Reporting Person's continuous service through that date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes 178,879 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":558437,"source":{"system":"sec-edgar","filing":"0000939767-21-000010","document":"wf-form4_161257775017168.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000010/wf-form4_161257775017168.xml","form_type":"4"}},{"id":2877817,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2021-02-06T02:16:03.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":9745,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Exelixis, Inc. common stock issued to the Reporting Person upon vesting of restricted stock units.  Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"On September 10, 2018, the Reporting Person was granted a performance-based restricted stock unit (\"PSU\") award under the Exelixis, Inc. 2017 Equity Incentive Plan covering 9,745 shares of common stock (such award, the \"2018 Award\"). The 2018 Award generally vests as follows: (i) 50% of the original number of shares subject to the 2018 Award vest upon certification by the Compensation Committee (the \"Committee\") that Exelixis has achieved certain performance criteria related to clinical trial enrollment or positive top-line results (the \"2018 Goal\"); and (ii) 50% of the original number of shares subject to the 2018 Award will vest on the first quarterly PSU vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the one-year anniversary of the Committee's certification."},{"field":"shares","element":"transactionShares","label":"F3","text":"On February 3, 2021, the Committee convened to determine that the 2018 Goal had been achieved, resulting in the immediate vesting of 50% of the 2018 Award, and the remaining 50% will vest on February 15, 2022, subject to the Reporting Person's continuous service through that date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 143,232 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":487144,"source":{"system":"sec-edgar","filing":"0000939767-21-000010","document":"wf-form4_161257775017168.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976721000010/wf-form4_161257775017168.xml","form_type":"4"}},{"id":2978413,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2020-11-18T00:57:35.000Z","date":"2020-11-15","kind":"tax_withholding","acquired":false,"shares":2583,"price":20.16,"value":52073.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded on September 22, 2016."}],"balance_after":477399,"source":{"system":"sec-edgar","filing":"0000939767-20-000152","document":"wf-form4_160566103821240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000152/wf-form4_160566103821240.xml","form_type":"4"}},{"id":2978412,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2020-11-18T00:57:35.000Z","date":"2020-11-15","kind":"tax_withholding","acquired":false,"shares":9685,"price":20.16,"value":195249.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded on October 3, 2017."}],"balance_after":479982,"source":{"system":"sec-edgar","filing":"0000939767-20-000152","document":"wf-form4_160566103821240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000152/wf-form4_160566103821240.xml","form_type":"4"}},{"id":2978411,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2020-11-18T00:57:35.000Z","date":"2020-11-15","kind":"tax_withholding","acquired":false,"shares":2685,"price":20.16,"value":54129.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of performance-based restricted stock units awarded on September 10, 2018, for which the Compensation Committee certified that Exelixis, Inc. had achieved the performance goal on September 12, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 138,359 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 517 shares of Exelixis, Inc. common stock acquired on October 30, 2020, pursuant to the Exelixis, Inc. 2000 Employee Stock Purchase Plan."}],"balance_after":489667,"source":{"system":"sec-edgar","filing":"0000939767-20-000152","document":"wf-form4_160566103821240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000152/wf-form4_160566103821240.xml","form_type":"4"}},{"id":3000195,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2020-10-27T00:11:11.000Z","date":"2020-10-22","kind":"tax_withholding","acquired":false,"shares":55235,"price":21.79,"value":1203570.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of certain restricted stock units earned on October 22, 2020."}],"balance_after":491835,"source":{"system":"sec-edgar","filing":"0000939767-20-000140","document":"wf-form4_160375744915237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000140/wf-form4_160375744915237.xml","form_type":"4"}},{"id":3000194,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2020-10-27T00:11:11.000Z","date":"2020-10-22","kind":"grant","acquired":true,"shares":213879,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Exelixis, Inc. common stock issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"On September 20, 2019, the Reporting Person was granted a performance-based restricted stock unit award (\"PSU\") under the Exelixis, Inc. 2017 Equity Incentive Plan covering 142,586 shares of common stock (such shares, the \"Target Shares\"). The PSU generally vests as follows: (i) 50% of the Target Shares vest upon the Committee's certification of achievement certain performance criteria as certified by the Compensation Committee (the \"Committee\"); and (ii) 50% of the Target Shares vest on the first quarterly PSU vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the one-year anniversary of the Committee's certification. In addition, the PSU provides for vesting of up to a maximum of 200% of the Target Shares depending on the timing and level of achievement of the performance criteria provided for under the PSU."},{"field":"shares","element":"transactionShares","label":"F3","text":"On October 22, 2020, the Committee determined that certain performance criteria had been achieved, resulting in the Reporting Person's eligibility to vest up to 150% of the Target Shares subject to the PSU. Accordingly, the Committee's certification resulted in the immediate vesting of 75% of the Target Shares, and 75% of the Target Shares will vest on November 15, 2021, subject to the Reporting Person's continuous service through that date.  The Reporting Person remains eligible for additional vesting depending the level and timing of achievement of the performance criteria through December 31, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 167,307 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":547070,"source":{"system":"sec-edgar","filing":"0000939767-20-000140","document":"wf-form4_160375744915237.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000140/wf-form4_160375744915237.xml","form_type":"4"}},{"id":3038078,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2020-09-04T22:32:57.000Z","date":"2020-09-02","kind":"tax_withholding","acquired":false,"shares":2517,"price":21.58,"value":54316.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of certain restricted stock units earned on September 2, 2020."}],"balance_after":333191,"source":{"system":"sec-edgar","filing":"0000939767-20-000123","document":"wf-form4_159925876404670.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000123/wf-form4_159925876404670.xml","form_type":"4"}},{"id":3038077,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2020-09-04T22:32:57.000Z","date":"2020-09-02","kind":"grant","acquired":true,"shares":9745,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Exelixis, Inc. common stock issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"On September 10, 2018, the Reporting Person was granted a performance-based restricted stock unit (\"PSU\") award of 9,745 shares of common stock under the Exelixis, Inc. 2017 Equity Incentive Plan. Vesting of the PSU award is tied to performance goals set by the Compensation Committee (the \"Committee\") as follows: (i) 50% of the original number of shares subject to the award will vest upon the Committee's certification that a target number of potentially label-enabling clinical trials evaluating cabozantinib (both alone or in combination with another therapy) have been initiated; and (ii) 50% of the original number of shares subject to the award will vest on the first quarterly PSU vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the one-year anniversary of the Committee's certification."},{"field":"shares","element":"transactionShares","label":"F3","text":"On September 2, 2020, the Committee convened to determine that the target number of clinical trial initiations had been achieved, resulting in the immediate vesting of 50% of the PSU award, and the remaining 50% will vest on November 15, 2021, subject to the Reporting Person's continuous service through that date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 60,367 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":335708,"source":{"system":"sec-edgar","filing":"0000939767-20-000123","document":"wf-form4_159925876404670.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000123/wf-form4_159925876404670.xml","form_type":"4"}},{"id":3121076,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Option (right to buy)","published_at":"2020-06-06T00:00:03.000Z","date":"2020-06-04","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, representing the right to purchase a total of 500,000 shares of Exelixis, Inc. common stock, became fully exercisable on April 28, 2016."}],"balance_after":200000,"derivative":{"exercise_price":1.7,"exercise_date":"2015-07-20","expiration_date":"2021-09-18","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000939767-20-000102","document":"wf-form4_159140158560171.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000102/wf-form4_159140158560171.xml","form_type":"4"}},{"id":3121075,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2020-06-06T00:00:03.000Z","date":"2020-06-04","kind":"sale","acquired":false,"shares":100000,"price":22.96,"value":2296000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 9, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.47 to $23.46. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4."}],"balance_after":325963,"source":{"system":"sec-edgar","filing":"0000939767-20-000102","document":"wf-form4_159140158560171.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000102/wf-form4_159140158560171.xml","form_type":"4"}},{"id":3121074,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2020-06-06T00:00:03.000Z","date":"2020-06-04","kind":"exercise","acquired":true,"shares":100000,"price":1.7,"value":170000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 55,494 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 841 shares of common stock acquired on April 30, 2020, pursuant to the Exelixis, Inc. 2000 Employee Stock Purchase Plan."}],"balance_after":425963,"source":{"system":"sec-edgar","filing":"0000939767-20-000102","document":"wf-form4_159140158560171.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000102/wf-form4_159140158560171.xml","form_type":"4"}},{"id":3170540,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Option (right to buy)","published_at":"2020-04-25T00:25:58.000Z","date":"2020-04-23","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, representing the right to purchase a total of 500,000 shares of Exelixis, Inc. common stock, became fully exercisable on April 28, 2016."}],"balance_after":300000,"derivative":{"exercise_price":1.7,"exercise_date":"2015-07-20","expiration_date":"2021-09-18","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000939767-20-000057","document":"wf-form4_158777434060565.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000057/wf-form4_158777434060565.xml","form_type":"4"}},{"id":3170539,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2020-04-25T00:25:58.000Z","date":"2020-04-23","kind":"sale","acquired":false,"shares":100000,"price":26,"value":2600000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 9, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $26.00 to $26.05. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4."}],"balance_after":325122,"source":{"system":"sec-edgar","filing":"0000939767-20-000057","document":"wf-form4_158777434060565.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000057/wf-form4_158777434060565.xml","form_type":"4"}},{"id":3170538,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2020-04-25T00:25:58.000Z","date":"2020-04-23","kind":"exercise","acquired":true,"shares":100000,"price":1.7,"value":170000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 55,494 shares of Exelixis, Inc. common stock (\"Common Stock\") that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":425122,"source":{"system":"sec-edgar","filing":"0000939767-20-000057","document":"wf-form4_158777434060565.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000057/wf-form4_158777434060565.xml","form_type":"4"}},{"id":3223322,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Option (right to buy)","published_at":"2020-03-07T01:01:35.000Z","date":"2020-03-04","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, representing the right to purchase a total of 500,000 shares of Exelixis, Inc. common stock, became fully exercisable on April 28, 2016."}],"balance_after":400000,"derivative":{"exercise_price":1.7,"exercise_date":"2015-07-20","expiration_date":"2021-09-18","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000939767-20-000042","document":"wf-form4_158354287693678.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000042/wf-form4_158354287693678.xml","form_type":"4"}},{"id":3223321,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2020-03-07T01:01:35.000Z","date":"2020-03-04","kind":"sale","acquired":false,"shares":50000,"price":19.6,"value":980000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $19.60 to $19.62. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4."}],"balance_after":325122,"source":{"system":"sec-edgar","filing":"0000939767-20-000042","document":"wf-form4_158354287693678.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000042/wf-form4_158354287693678.xml","form_type":"4"}},{"id":3223320,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2020-03-07T01:01:35.000Z","date":"2020-03-04","kind":"sale","acquired":false,"shares":50000,"price":19.2,"value":960000.0,"ownership":{"direct":true},"balance_after":375122,"source":{"system":"sec-edgar","filing":"0000939767-20-000042","document":"wf-form4_158354287693678.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000042/wf-form4_158354287693678.xml","form_type":"4"}},{"id":3223319,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2020-03-07T01:01:35.000Z","date":"2020-03-04","kind":"exercise","acquired":true,"shares":100000,"price":1.7,"value":170000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 55,494 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":425122,"source":{"system":"sec-edgar","filing":"0000939767-20-000042","document":"wf-form4_158354287693678.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000042/wf-form4_158354287693678.xml","form_type":"4"}},{"id":3257536,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Option (right to buy)","published_at":"2020-02-22T01:00:57.000Z","date":"2020-02-19","kind":"exercise","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, representing the right to purchase a total of 240,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 18, 2017."}],"balance_after":0,"derivative":{"exercise_price":5.51,"exercise_date":"2014-09-18","expiration_date":"2020-09-17","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000939767-20-000025","document":"wf-form4_158233323874710.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000025/wf-form4_158233323874710.xml","form_type":"4"}},{"id":3257535,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2020-02-22T01:00:57.000Z","date":"2020-02-19","kind":"sale","acquired":false,"shares":40000,"price":21.5,"value":860000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 9, 2020."}],"balance_after":325122,"source":{"system":"sec-edgar","filing":"0000939767-20-000025","document":"wf-form4_158233323874710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000025/wf-form4_158233323874710.xml","form_type":"4"}},{"id":3257534,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2020-02-22T01:00:57.000Z","date":"2020-02-19","kind":"exercise","acquired":true,"shares":40000,"price":5.51,"value":220400.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 55,494 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":365122,"source":{"system":"sec-edgar","filing":"0000939767-20-000025","document":"wf-form4_158233323874710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000025/wf-form4_158233323874710.xml","form_type":"4"}},{"id":3266695,"issuer":{"id":12635,"kind":"organization","name":"GENOCEA BIOSCIENCES, INC.","symbol":"GNCA"},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-18T16:41:36.000Z","date":"2020-02-14","kind":"grant","acquired":true,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest 33 1/3% on each of February 14, 2021, February 14, 2022, and February 14, 2023"}],"balance_after":9375,"derivative":{"exercise_price":2.1,"expiration_date":"2030-02-14","underlying":"Common Stock","underlying_shares":9375},"source":{"system":"sec-edgar","filing":"0001457612-20-000020","document":"wf-form4_158206207720739.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1457612/000145761220000020/wf-form4_158206207720739.xml","form_type":"4"}},{"id":3285220,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Option (right to buy)","published_at":"2020-02-08T01:43:17.000Z","date":"2020-02-07","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, representing the right to purchase a total of 240,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 18, 2017."}],"balance_after":40000,"derivative":{"exercise_price":5.51,"exercise_date":"2014-09-18","expiration_date":"2020-09-17","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000939767-20-000014","document":"wf-form4_158112617928288.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000014/wf-form4_158112617928288.xml","form_type":"4"}},{"id":3285219,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2020-02-08T01:43:17.000Z","date":"2020-02-07","kind":"sale","acquired":false,"shares":50000,"price":18.37,"value":918500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 9, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $18.14 to $18.62. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4."}],"balance_after":325122,"source":{"system":"sec-edgar","filing":"0000939767-20-000014","document":"wf-form4_158112617928288.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000014/wf-form4_158112617928288.xml","form_type":"4"}},{"id":3285218,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2020-02-08T01:43:17.000Z","date":"2020-02-07","kind":"exercise","acquired":true,"shares":50000,"price":5.51,"value":275500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 55,494 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":375122,"source":{"system":"sec-edgar","filing":"0000939767-20-000014","document":"wf-form4_158112617928288.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000014/wf-form4_158112617928288.xml","form_type":"4"}},{"id":3314695,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Option (right to buy)","published_at":"2020-01-10T01:27:40.000Z","date":"2020-01-07","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, representing the right to purchase a total of 240,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 18, 2017."}],"balance_after":90000,"derivative":{"exercise_price":5.51,"exercise_date":"2014-09-18","expiration_date":"2020-09-17","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000939767-20-000002","document":"wf-form4_157861964149710.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000002/wf-form4_157861964149710.xml","form_type":"4"}},{"id":3314694,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2020-01-10T01:27:40.000Z","date":"2020-01-07","kind":"sale","acquired":false,"shares":50000,"price":17.96,"value":898000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 9, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $17.62 to $18.25. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4."}],"balance_after":325122,"source":{"system":"sec-edgar","filing":"0000939767-20-000002","document":"wf-form4_157861964149710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000002/wf-form4_157861964149710.xml","form_type":"4"}},{"id":3314693,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2020-01-10T01:27:40.000Z","date":"2020-01-07","kind":"exercise","acquired":true,"shares":50000,"price":5.51,"value":275500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 55,494 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":375122,"source":{"system":"sec-edgar","filing":"0000939767-20-000002","document":"wf-form4_157861964149710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976720000002/wf-form4_157861964149710.xml","form_type":"4"}},{"id":3350200,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2019-12-07T00:23:28.000Z","date":"2019-12-04","kind":"tax_withholding","acquired":false,"shares":4027,"price":17.67,"value":71157.09,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of certain restricted stock units earned on December 4, 2019."}],"balance_after":325122,"source":{"system":"sec-edgar","filing":"0000939767-19-000204","document":"wf-form4_157567819018369.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000204/wf-form4_157567819018369.xml","form_type":"4"}},{"id":3350199,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2019-12-07T00:23:28.000Z","date":"2019-12-04","kind":"grant","acquired":true,"shares":15592,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Exelixis, Inc. common stock issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"On September 10, 2018, the Reporting Person was granted a performance-based restricted stock unit (\"PSU\") award of 15,592 shares of common stock under the Exelixis, Inc. 2017 Equity Incentive Plan.  Vesting of the PSU award is tied to performance goals set by the Compensation Committee (the \"Committee\") as follows: (i) 50% of the original number of shares subject to the award will vest upon the Committee's certification that Exelixis, Inc. has achieved a net product revenue target over four consecutive fiscal quarters; and (ii) 50% of the original number of shares subject to the award will vest on the first quarterly PSU vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the one-year anniversary of the Committee's certification."},{"field":"shares","element":"transactionShares","label":"F3","text":"On December 4, 2019, the Committee convened to determine that the net product revenue target over four consecutive fiscal quarters had been achieved during the three months ended September 27, 2019, resulting in the immediate vesting of 50% of the PSU award, and the remaining 50% will vest on February 15, 2021, subject to the Reporting Person's continuous service through that date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 55,494 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":329149,"source":{"system":"sec-edgar","filing":"0000939767-19-000204","document":"wf-form4_157567819018369.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000204/wf-form4_157567819018369.xml","form_type":"4"}},{"id":3351434,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Option (right to buy)","published_at":"2019-12-06T01:11:50.000Z","date":"2019-12-03","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, representing the right to purchase a total of 240,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 18, 2017."}],"balance_after":140000,"derivative":{"exercise_price":5.51,"exercise_date":"2014-09-18","expiration_date":"2020-09-17","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000939767-19-000198","document":"wf-form4_157559469250020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000198/wf-form4_157559469250020.xml","form_type":"4"}},{"id":3351433,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2019-12-06T01:11:50.000Z","date":"2019-12-03","kind":"sale","acquired":false,"shares":50000,"price":16.22,"value":811000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 9, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $16.06 to $16.58. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4."}],"balance_after":313557,"source":{"system":"sec-edgar","filing":"0000939767-19-000198","document":"wf-form4_157559469250020.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000198/wf-form4_157559469250020.xml","form_type":"4"}},{"id":3351432,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2019-12-06T01:11:50.000Z","date":"2019-12-03","kind":"exercise","acquired":true,"shares":50000,"price":5.51,"value":275500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 47,698 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":363557,"source":{"system":"sec-edgar","filing":"0000939767-19-000198","document":"wf-form4_157559469250020.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000198/wf-form4_157559469250020.xml","form_type":"4"}},{"id":3370432,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2019-11-16T02:39:54.000Z","date":"2019-11-15","kind":"tax_withholding","acquired":false,"shares":2583,"price":16.51,"value":42645.33,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded September 22, 2016."}],"balance_after":313557,"source":{"system":"sec-edgar","filing":"0000939767-19-000196","document":"wf-form4_157387197627466.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000196/wf-form4_157387197627466.xml","form_type":"4"}},{"id":3370431,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2019-11-16T02:39:54.000Z","date":"2019-11-15","kind":"tax_withholding","acquired":false,"shares":9685,"price":16.51,"value":159899.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded October 3, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 47,698 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 888 and 606 shares of common stock acquired on April 30, 2019 and October 31, 2019, respectively, pursuant to the Exelixis, Inc. 2000 Employee Stock Purchase Plan."}],"balance_after":316140,"source":{"system":"sec-edgar","filing":"0000939767-19-000196","document":"wf-form4_157387197627466.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000196/wf-form4_157387197627466.xml","form_type":"4"}},{"id":3379114,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Option (right to buy)","published_at":"2019-11-07T00:55:16.000Z","date":"2019-11-04","kind":"exercise","acquired":false,"shares":50000,"price":5.51,"value":275500.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, representing the right to purchase a total of 240,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 18, 2017."}],"balance_after":190000,"derivative":{"exercise_price":5.51,"exercise_date":"2014-09-18","expiration_date":"2020-09-17","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000939767-19-000191","document":"wf-form4_157308810085909.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000191/wf-form4_157308810085909.xml","form_type":"4"}},{"id":3379113,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2019-11-07T00:55:16.000Z","date":"2019-11-04","kind":"sale","acquired":false,"shares":50000,"price":15.99,"value":799500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 9, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $15.81 to $16.16. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4."}],"balance_after":324331,"source":{"system":"sec-edgar","filing":"0000939767-19-000191","document":"wf-form4_157308810085909.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000191/wf-form4_157308810085909.xml","form_type":"4"}},{"id":3379112,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2019-11-07T00:55:16.000Z","date":"2019-11-04","kind":"exercise","acquired":true,"shares":50000,"price":5.51,"value":275500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 71,448 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":374331,"source":{"system":"sec-edgar","filing":"0000939767-19-000191","document":"wf-form4_157308810085909.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000191/wf-form4_157308810085909.xml","form_type":"4"}},{"id":3399353,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Option (right to buy)","published_at":"2019-10-04T01:03:18.000Z","date":"2019-10-01","kind":"exercise","acquired":false,"shares":30000,"price":5.51,"value":165300.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, representing the right to purchase a total of 160,000 shares of Exelixis, Inc. common stock, became exercisable as to 50% of such stock option on July 20, 2015 upon the satisfaction of one of the two performance goals set by the Compensation Committee. On December 10, 2014, the Compensation Committee determined that the second performance goal for the option had not, and would not, be achieved, resulting in the Reporting Person forfeiting the remaining 50% of such stock option."}],"balance_after":0,"derivative":{"exercise_price":5.51,"exercise_date":"2015-07-20","expiration_date":"2020-09-17","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000939767-19-000178","document":"wf-form4_157015097510585.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000178/wf-form4_157015097510585.xml","form_type":"4"}},{"id":3399352,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2019-10-04T01:03:18.000Z","date":"2019-10-01","kind":"sale","acquired":false,"shares":30000,"price":17.87,"value":536100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 9, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $17.63 to $18.02. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4."}],"balance_after":324331,"source":{"system":"sec-edgar","filing":"0000939767-19-000178","document":"wf-form4_157015097510585.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000178/wf-form4_157015097510585.xml","form_type":"4"}},{"id":3399351,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2019-10-04T01:03:18.000Z","date":"2019-10-01","kind":"exercise","acquired":true,"shares":30000,"price":5.51,"value":165300.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 71,448 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":354331,"source":{"system":"sec-edgar","filing":"0000939767-19-000178","document":"wf-form4_157015097510585.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000178/wf-form4_157015097510585.xml","form_type":"4"}},{"id":3415353,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2019-09-14T00:13:50.000Z","date":"2019-09-12","kind":"tax_withholding","acquired":false,"shares":2577,"price":19.26,"value":49633.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of certain restricted stock units earned on September 12, 2019."}],"balance_after":324331,"source":{"system":"sec-edgar","filing":"0000939767-19-000168","document":"wf-form4_156842001268353.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000168/wf-form4_156842001268353.xml","form_type":"4"}},{"id":3415352,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2019-09-14T00:13:50.000Z","date":"2019-09-12","kind":"grant","acquired":true,"shares":10395,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of Exelixis, Inc. common stock issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"On September 10, 2018, the Reporting Person was granted a performance-based restricted stock unit (\"PSU\") award of 10,395 shares of common stock under the Exelixis, Inc. 2017 Equity Incentive Plan.  Vesting of the PSU award is tied to performance goals set by the Compensation Committee (the \"Committee\") as follows: (i) 50% of the original number of shares subject to the award will vest upon the Compensation Committee's certification that Exelixis, Inc. has achieved a quarterly net product revenue target; and (ii) 50% of the original number of shares subject to the award will vest on the first quarterly PSU vesting date (i.e. February 15th, May 15th, August 15th and November 15th) following the one-year anniversary of the Committee's certification."},{"field":"shares","element":"transactionShares","label":"F3","text":"On September 12, 2019, the Committee convened to determine that the quarterly net product revenue target had been achieved during the three months ended June 28, 2019, resulting in the immediate vesting of 50% of the PSU award, and the remaining 50% will vest on November 15, 2020, subject to the Reporting Person's continuous service through that date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 71,448 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":326908,"source":{"system":"sec-edgar","filing":"0000939767-19-000168","document":"wf-form4_156842001268353.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000168/wf-form4_156842001268353.xml","form_type":"4"}},{"id":3566320,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Option (right to buy)","published_at":"2019-04-04T00:17:15.000Z","date":"2019-04-03","kind":"exercise","acquired":false,"shares":63109,"price":7.18,"value":453122.62,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, representing the right to purchase a total of 210,000 shares of Exelixis, Inc. common stock, became fully exercisable on December 9, 2013."}],"balance_after":0,"derivative":{"exercise_price":7.18,"exercise_date":"2010-12-09","expiration_date":"2019-12-08","underlying":"Common Stock","underlying_shares":63109},"source":{"system":"sec-edgar","filing":"0000939767-19-000086","document":"wf-form4_155433702016937.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000086/wf-form4_155433702016937.xml","form_type":"4"}},{"id":3566319,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2019-04-04T00:17:15.000Z","date":"2019-04-03","kind":"sale","acquired":false,"shares":63109,"price":25,"value":1577725.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 21, 2019."}],"balance_after":316513,"source":{"system":"sec-edgar","filing":"0000939767-19-000086","document":"wf-form4_155433702016937.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000086/wf-form4_155433702016937.xml","form_type":"4"}},{"id":3566318,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2019-04-04T00:17:15.000Z","date":"2019-04-03","kind":"exercise","acquired":true,"shares":63109,"price":7.18,"value":453122.62,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 66,250 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":379622,"source":{"system":"sec-edgar","filing":"0000939767-19-000086","document":"wf-form4_155433702016937.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000086/wf-form4_155433702016937.xml","form_type":"4"}},{"id":3577426,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Option (right to buy)","published_at":"2019-03-28T00:33:48.000Z","date":"2019-03-25","kind":"exercise","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, representing the right to purchase a total of 195,409 shares of Exelixis, Inc. common stock, became fully exercisable on December 9, 2013."}],"balance_after":63109,"derivative":{"exercise_price":7.18,"exercise_date":"2010-12-09","expiration_date":"2019-12-08","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000939767-19-000071","document":"wf-form4_155373321327183.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000071/wf-form4_155373321327183.xml","form_type":"4"}},{"id":3577425,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2019-03-28T00:33:48.000Z","date":"2019-03-25","kind":"sale","acquired":false,"shares":100000,"price":23.14,"value":2314000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 21, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.31. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4."}],"balance_after":316513,"source":{"system":"sec-edgar","filing":"0000939767-19-000071","document":"wf-form4_155373321327183.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000071/wf-form4_155373321327183.xml","form_type":"4"}},{"id":3577424,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2019-03-28T00:33:48.000Z","date":"2019-03-25","kind":"exercise","acquired":true,"shares":100000,"price":7.18,"value":718000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 66,250 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":416513,"source":{"system":"sec-edgar","filing":"0000939767-19-000071","document":"wf-form4_155373321327183.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000071/wf-form4_155373321327183.xml","form_type":"4"}},{"id":3654642,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Option (right to buy)","published_at":"2019-02-16T01:11:10.000Z","date":"2019-02-15","kind":"exercise","acquired":false,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, representing the right to purchase a total of 123,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 21, 2016."}],"balance_after":0,"derivative":{"exercise_price":5.56,"exercise_date":"2013-09-21","expiration_date":"2019-09-20","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0000939767-19-000027","document":"wf-form4_155027943888006.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000027/wf-form4_155027943888006.xml","form_type":"4"}},{"id":3654641,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Option (right to buy)","published_at":"2019-02-16T01:11:10.000Z","date":"2019-02-14","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option, representing the right to purchase a total of 123,000 shares of Exelixis, Inc. common stock, became fully exercisable on September 21, 2016."}],"balance_after":23000,"derivative":{"exercise_price":5.56,"exercise_date":"2013-09-21","expiration_date":"2019-09-20","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000939767-19-000027","document":"wf-form4_155027943888006.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000027/wf-form4_155027943888006.xml","form_type":"4"}},{"id":3654640,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2019-02-16T01:11:10.000Z","date":"2019-02-15","kind":"sale","acquired":false,"shares":23000,"price":22.2,"value":510600.0,"ownership":{"direct":true},"balance_after":316513,"source":{"system":"sec-edgar","filing":"0000939767-19-000027","document":"wf-form4_155027943888006.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000027/wf-form4_155027943888006.xml","form_type":"4"}},{"id":3654639,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2019-02-16T01:11:10.000Z","date":"2019-02-15","kind":"exercise","acquired":true,"shares":23000,"price":5.56,"value":127880.0,"ownership":{"direct":true},"balance_after":339513,"source":{"system":"sec-edgar","filing":"0000939767-19-000027","document":"wf-form4_155027943888006.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000027/wf-form4_155027943888006.xml","form_type":"4"}},{"id":3654638,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2019-02-16T01:11:10.000Z","date":"2019-02-14","kind":"sale","acquired":false,"shares":100000,"price":21.66,"value":2166000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.39 to $22.02 Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4."}],"balance_after":316513,"source":{"system":"sec-edgar","filing":"0000939767-19-000027","document":"wf-form4_155027943888006.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000027/wf-form4_155027943888006.xml","form_type":"4"}},{"id":3654637,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2019-02-16T01:11:10.000Z","date":"2019-02-14","kind":"exercise","acquired":true,"shares":100000,"price":5.56,"value":556000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 66,250 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":416513,"source":{"system":"sec-edgar","filing":"0000939767-19-000027","document":"wf-form4_155027943888006.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976719000027/wf-form4_155027943888006.xml","form_type":"4"}},{"id":3746646,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Option (right to buy)","published_at":"2018-12-04T01:00:29.000Z","date":"2018-12-03","kind":"exercise","acquired":false,"shares":13499,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, representing the right to purchase a total of 50,000 shares of Exelixis, Inc. common stock, became fully exercisable on December 16, 2012."}],"balance_after":0,"derivative":{"exercise_price":5.04,"exercise_date":"2009-12-16","expiration_date":"2018-12-15","underlying":"Common Stock","underlying_shares":13499},"source":{"system":"sec-edgar","filing":"0000939767-18-000244","document":"wf-form4_154388521379385.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976718000244/wf-form4_154388521379385.xml","form_type":"4"}},{"id":3746645,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2018-12-04T01:00:29.000Z","date":"2018-12-03","kind":"sale","acquired":false,"shares":13499,"price":21.02,"value":283748.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 2, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.82 to $21.27. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4."}],"balance_after":316513,"source":{"system":"sec-edgar","filing":"0000939767-18-000244","document":"wf-form4_154388521379385.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976718000244/wf-form4_154388521379385.xml","form_type":"4"}},{"id":3746644,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2018-12-04T01:00:29.000Z","date":"2018-12-03","kind":"exercise","acquired":true,"shares":13499,"price":5.04,"value":68034.96,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 66,250 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":330012,"source":{"system":"sec-edgar","filing":"0000939767-18-000244","document":"wf-form4_154388521379385.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976718000244/wf-form4_154388521379385.xml","form_type":"4"}},{"id":3762056,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2018-11-17T01:24:32.000Z","date":"2018-11-15","kind":"tax_withholding","acquired":false,"shares":2479,"price":17.45,"value":43258.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded September 22, 2016."}],"balance_after":316513,"source":{"system":"sec-edgar","filing":"0000939767-18-000236","document":"wf-form4_154241785504509.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976718000236/wf-form4_154241785504509.xml","form_type":"4"}},{"id":3762055,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2018-11-17T01:24:32.000Z","date":"2018-11-15","kind":"tax_withholding","acquired":false,"shares":9296,"price":17.45,"value":162215.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded October 3, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 66,250 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":318992,"source":{"system":"sec-edgar","filing":"0000939767-18-000236","document":"wf-form4_154241785504509.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976718000236/wf-form4_154241785504509.xml","form_type":"4"}},{"id":3777089,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Option (right to buy)","published_at":"2018-11-03T00:05:06.000Z","date":"2018-11-01","kind":"exercise","acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, representing the right to purchase a total of 50,000 shares of Exelixis, Inc. common stock, became fully exercisable on December 16, 2012."}],"balance_after":13499,"derivative":{"exercise_price":5.04,"exercise_date":"2009-12-16","expiration_date":"2018-12-15","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000939767-18-000224","document":"wf-form4_154120348927155.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976718000224/wf-form4_154120348927155.xml","form_type":"4"}},{"id":3777088,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2018-11-03T00:05:06.000Z","date":"2018-11-01","kind":"sale","acquired":false,"shares":12000,"price":14.16,"value":169920.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 2, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $13.89 to $14.39. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4."}],"balance_after":328288,"source":{"system":"sec-edgar","filing":"0000939767-18-000224","document":"wf-form4_154120348927155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976718000224/wf-form4_154120348927155.xml","form_type":"4"}},{"id":3777087,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2018-11-03T00:05:06.000Z","date":"2018-11-01","kind":"exercise","acquired":true,"shares":12000,"price":5.04,"value":60480.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 90,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":340288,"source":{"system":"sec-edgar","filing":"0000939767-18-000224","document":"wf-form4_154120348927155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976718000224/wf-form4_154120348927155.xml","form_type":"4"}},{"id":3799500,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Option (right to buy)","published_at":"2018-10-04T00:08:42.000Z","date":"2018-10-01","kind":"exercise","acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, representing the right to purchase a total of 50,000 shares of Exelixis, Inc. common stock, became fully exercisable on December 16, 2012."}],"balance_after":25499,"derivative":{"exercise_price":5.04,"exercise_date":"2009-12-16","expiration_date":"2018-12-15","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000939767-18-000208","document":"wf-form4_153861170606263.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976718000208/wf-form4_153861170606263.xml","form_type":"4"}},{"id":3799499,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2018-10-04T00:08:42.000Z","date":"2018-10-01","kind":"sale","acquired":false,"shares":12000,"price":17.77,"value":213240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 2, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $17.65 to $17.93. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4."}],"balance_after":328288,"source":{"system":"sec-edgar","filing":"0000939767-18-000208","document":"wf-form4_153861170606263.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976718000208/wf-form4_153861170606263.xml","form_type":"4"}},{"id":3799498,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2018-10-04T00:08:42.000Z","date":"2018-10-01","kind":"exercise","acquired":true,"shares":12000,"price":5.04,"value":60480.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 90,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":340288,"source":{"system":"sec-edgar","filing":"0000939767-18-000208","document":"wf-form4_153861170606263.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976718000208/wf-form4_153861170606263.xml","form_type":"4"}},{"id":3818828,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres, Prod Dev & Med Aff & CMO"}}],"security":"Option (right to buy)","published_at":"2018-09-13T00:14:11.000Z","date":"2018-09-10","kind":"grant","acquired":true,"shares":129314,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option granted pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. Option granted will vest as to 1/4th of the original number of shares subject to the option on the one-year anniversary of the Transaction Date, and thereafter as to 1/48th of the original number of shares subject to the option on each monthly anniversary of the Transaction Date."}],"balance_after":129314,"derivative":{"exercise_price":18.8,"exercise_date":"2019-09-10","expiration_date":"2025-09-09","underlying":"Common Stock","underlying_shares":129314},"source":{"system":"sec-edgar","filing":"0000939767-18-000201","document":"wf-form4_153679763393195.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976718000201/wf-form4_153679763393195.xml","form_type":"4"}},{"id":3824186,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2018-09-07T00:00:09.000Z","date":"2018-09-04","kind":"exercise","acquired":false,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, representing the right to purchase a total of 112,500 shares of Exelixis, Inc. common stock, became fully exercisable on September 28, 2015."}],"balance_after":0,"derivative":{"exercise_price":5.5,"exercise_date":"2012-09-28","expiration_date":"2018-09-27","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0000939767-18-000190","document":"wf-form4_153627839293160.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976718000190/wf-form4_153627839293160.xml","form_type":"4"}},{"id":3824185,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2018-09-07T00:00:09.000Z","date":"2018-09-04","kind":"sale","acquired":false,"shares":22500,"price":18.53,"value":416925.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 2, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $18.37 to $18.70. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4."}],"balance_after":328288,"source":{"system":"sec-edgar","filing":"0000939767-18-000190","document":"wf-form4_153627839293160.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976718000190/wf-form4_153627839293160.xml","form_type":"4"}},{"id":3824184,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2018-09-07T00:00:09.000Z","date":"2018-09-04","kind":"exercise","acquired":true,"shares":22500,"price":5.5,"value":123750.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 90,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":350788,"source":{"system":"sec-edgar","filing":"0000939767-18-000190","document":"wf-form4_153627839293160.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976718000190/wf-form4_153627839293160.xml","form_type":"4"}},{"id":3838842,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres Prod Dev & Med Aff & CMO"}}],"security":"Option (right to buy)","published_at":"2018-08-21T00:10:43.000Z","date":"2018-08-17","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, representing the right to purchase a total of 160,000 shares of Exelixis, Inc. common stock, became exercisable as to 50% of such stock option on July 20, 2015 upon the satisfaction of one of the two performance goals set by the Compensation Committee.  On December 10, 2014, the Compensation Committee determined that the second performance goal for the option had not, and would not, be achieved, resulting in the Reporting Person forfeiting the remaining 50% of such stock option."}],"balance_after":30000,"derivative":{"exercise_price":5.51,"exercise_date":"2015-07-20","expiration_date":"2020-09-17","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000939767-18-000186","document":"wf-form4_153481022676695.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976718000186/wf-form4_153481022676695.xml","form_type":"4"}},{"id":3838841,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2018-08-21T00:10:43.000Z","date":"2018-08-17","kind":"exercise","acquired":true,"shares":50000,"price":5.51,"value":275500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 90,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":328288,"source":{"system":"sec-edgar","filing":"0000939767-18-000186","document":"wf-form4_153481022676695.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976718000186/wf-form4_153481022676695.xml","form_type":"4"}},{"id":3853919,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres Prod Dev & Med Aff & CMO"}}],"security":"Option (right to buy)","published_at":"2018-08-03T23:13:33.000Z","date":"2018-08-01","kind":"exercise","acquired":false,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, representing the right to purchase a total of 112,500 shares of Exelixis, Inc. common stock, became fully exercisable on September 28, 2015."}],"balance_after":22500,"derivative":{"exercise_price":5.5,"exercise_date":"2012-09-28","expiration_date":"2018-09-27","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0000939767-18-000174","document":"wf-form4_153333799764968.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976718000174/wf-form4_153333799764968.xml","form_type":"4"}},{"id":3853918,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2018-08-03T23:13:33.000Z","date":"2018-08-01","kind":"sale","acquired":false,"shares":22500,"price":20.56,"value":462600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 2, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.42 to $20.78. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4."}],"balance_after":278288,"source":{"system":"sec-edgar","filing":"0000939767-18-000174","document":"wf-form4_153333799764968.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976718000174/wf-form4_153333799764968.xml","form_type":"4"}},{"id":3853917,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres Prod Dev & Med Aff & CMO"}}],"security":"Common Stock","published_at":"2018-08-03T23:13:33.000Z","date":"2018-08-01","kind":"exercise","acquired":true,"shares":22500,"price":5.5,"value":123750.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 90,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units."}],"balance_after":300788,"source":{"system":"sec-edgar","filing":"0000939767-18-000174","document":"wf-form4_153333799764968.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976718000174/wf-form4_153333799764968.xml","form_type":"4"}},{"id":3876600,"issuer":{"id":3386,"kind":"organization","name":"EXELIXIS, INC."},"owners":[{"id":136922,"kind":"person","name":"Schwab Gisela","position":1,"cik":"0001213140","reported_name":"Schwab Gisela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres Prod Dev & Med Aff & CMO"}}],"security":"Option (right to buy)","published_at":"2018-07-04T01:07:51.000Z","date":"2018-07-02","kind":"exercise","acquired":false,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option, representing the right to purchase a total of 112,500 shares of Exelixis, Inc. common stock, became fully exercisable on September 28, 2015."}],"balance_after":45000,"derivative":{"exercise_price":5.5,"exercise_date":"2012-09-28","expiration_date":"2018-09-27","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0000939767-18-000123","document":"wf-form4_153066645574683.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/939767/000093976718000123/wf-form4_153066645574683.xml","form_type":"4"}}],"next_cursor":"2018-07-04T01:07:51.000000Z,3876600"}